Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene transfer therapy for heritable disease: cell and expression targeting

K Mitani1, P R Clemens, A B Moseley

  • 1Howard Hughes Medical Institute, Baylor College of Medicine, Houston, Texas 77030.

Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|February 27, 1993
PubMed
Summary

Gene therapy successfully targets hematopoietic stem cells for adenosine deaminase deficiency and utilizes gene truncation for Duchenne muscular dystrophy, advancing somatic gene therapy approaches.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular genetics of myotonic dystrophy.

Trends in cardiovascular medicine·2011
Same author

Monitoring expression of genes involved in drug metabolism and toxicology using DNA microarrays.

Physiological genomics·2001
Same author

Mesenchymal stem cells: biology and potential clinical uses.

Experimental hematology·2000
Same author

Identification of receptors for neuromedin U and its role in feeding.

Nature·2000
Same author

Optimization of the helper-dependent adenovirus system for production and potency in vivo.

Proceedings of the National Academy of Sciences of the United States of America·2000
Same author

Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster.

Proceedings of the National Academy of Sciences of the United States of America·2000

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Genetics

Background:

  • Gene therapy aims to cure diseases by delivering functional genes to somatic tissues.
  • Adenosine deaminase (ADA) deficiency and Duchenne muscular dystrophy (DMD) serve as key models for somatic gene therapy research.
  • Targeting specific cell populations like hematopoietic stem cells presents unique challenges.

Purpose of the Study:

  • To demonstrate efficient gene transfer and sustained expression of human ADA in hematopoietic progenitors.
  • To develop strategies for overcoming challenges in gene delivery for Duchenne muscular dystrophy, such as large gene size.

Main Methods:

  • Utilized retroviral supernatant with a supportive stromal layer for gene transfer of human ADA into primitive hematopoietic progenitors.

Related Experiment Videos

  • Transduced a stem cell-enriched (CD34+) fraction.
  • Employed a deletion mutagenesis strategy to truncate dystrophin cDNA for improved vector accommodation.

    • Main Results:

    • Achieved highly efficient gene transfer and sustained expression of human ADA in hematopoietic progenitors.
    • Successfully transduced CD34+ cells.
    • Demonstrated the feasibility of truncating dystrophin cDNA for use in retroviral and adenoviral vectors.

    Conclusions:

    • Somatic gene therapy is a viable approach for ADA deficiency using hematopoietic stem cell targeting.
    • Gene truncation strategies can facilitate the delivery of large genes like dystrophin for DMD gene therapy.
    • These findings advance the development of gene therapy for genetic disorders.